Chemical synthesis of benzamide adenine dinucleotide: Inhibition of inosine monophosphate dehydrogenase (types I and II)

被引:43
作者
Zatorski, A
Watanabe, KA
Carr, SF
Goldstein, BM
Pankiewicz, KW
机构
[1] ONCORPHARM INC, GAITHERSBURG, MD 20877 USA
[2] SLOAN KETTERING INST CANC RES, ORGAN CHEM LAB, NEW YORK, NY 10021 USA
[3] ROCHE BIOSCI, DEPT BIOCHEM, PALO ALTO, CA 94304 USA
[4] UNIV ROCHESTER, MED CTR, DEPT BIOPHYS, ROCHESTER, NY 14642 USA
关键词
D O I
10.1021/jm9601415
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Treatment of 3-(2,3-O-isopropylidene-beta-D-ribofuranosyl)benzamide (6) with POCl3 in (EtO)(3)-PO afforded only little phosphorylation product (8, 5%), but the major product was 5'-chlorobenzamide riboside (7, 85%). Reaction of 6 with 2-cyanoethyl N,N-diisopropylchlorophosphoramidite followed by 2-cyanoethanol/tetrazole treatment and oxidation with tert-butyl peroxide gave a 1:1 mixture of the desired 5'-O-bis(2-cyanoethyl) phosphate 9 and the chloro derivative 7. This mixture was treated with methanolic ammonia and partitioned between CHCl3 and water. The 2',3'-O-isopropylidenebenzamide mononucleotide (8) was obtained in 21.2% overall yield from the aqueous layer. Compound 8 was then converted into the corresponding imidazolide 11b which, upon coupling with 2',3'-O-acetonide of AMP, afforded the acetonide of benzamide adenine dinucleotide (15) in 94% yield together with small amounts of symmetrical pyrophosphates P-1, P-2-bis(2',3'-O-isopropylideneadenosin-5'-yl)pyrophosphate(13, 3%) and P-1, P-2-bis(2',3'-O-isopropylidene-3-(carbamoylphenyl)-5'-ribosyl)pyrophosphate (14, 2%). Deprotection of 15 with Dowex 50/H+ in water afforded the desired benzamide adenine dinucleotide (BAD) in 93% yield. BAD inhibits inosine monophosphate dehydrogenase type I (IC50 = 0.78 mu M) and type II (IC50 = 0.88 mu M) with same degree of potency.
引用
收藏
页码:2422 / 2426
页数:5
相关论文
共 31 条
[1]  
AGBARIA R, 1994, MOL PHARMACOL, V45, P777
[2]  
CARR SF, 1993, J BIOL CHEM, V268, P27286
[3]  
COLLART FR, 1992, CANCER RES, V52, P5826
[4]   THE CONVERSION OF 2-BETA-D-RIBOFURANOSYLTHIAZOLE-4-CARBOXAMIDE TO AN ANALOG OF NAD WITH POTENT IMP DEHYDROGENASE-INHIBITORY PROPERTIES [J].
COONEY, DA ;
JAYARAM, HN ;
GEBEYEHU, G ;
BETTS, CR ;
KELLEY, JA ;
MARQUEZ, VE ;
JOHNS, DG .
BIOCHEMICAL PHARMACOLOGY, 1982, 31 (11) :2133-2136
[5]  
FRIDLAND A, 1986, CANCER RES, V46, P532
[6]   RIBAVIRIN, TIAZOFURIN, AND SELENAZOFURIN - MONONUCLEOTIDES AND NICOTINAMIDE ADENINE-DINUCLEOTIDE ANALOGS - SYNTHESIS, STRUCTURE, AND INTERACTIONS WITH IMP DEHYDROGENASE [J].
GEBEYEHU, G ;
MARQUEZ, VE ;
VANCOTT, A ;
COONEY, DA ;
KELLEY, JA ;
JAYARAM, HN ;
AHLUWALIA, GS ;
DION, RL ;
WILSON, YA ;
JOHNS, DG .
JOURNAL OF MEDICINAL CHEMISTRY, 1985, 28 (01) :99-105
[7]   CYTOTOXICITY AND CHARACTERIZATION OF AN ACTIVE METABOLITE OF BENZAMIDE RIBOSIDE, A NOVEL INHIBITOR OF IMP DEHYDROGENASE [J].
GHAREHBAGHI, K ;
PAULL, KD ;
KELLEY, JA ;
BARCHI, JJ ;
MARQUEZ, VE ;
COONEY, DA ;
MONKS, A ;
SCUDIERO, D ;
KROHN, K ;
JAYARAM, HN .
INTERNATIONAL JOURNAL OF CANCER, 1994, 56 (06) :892-899
[8]   COMPARISON OF BIOCHEMICAL PARAMETERS OF BENZAMIDE RIBOSIDE, A NEW INHIBITOR OF IMP DEHYDROGENASE, WITH TIAZOFURIN AND SELENAZOFURIN [J].
GHAREHBAGHI, K ;
SREENATH, A ;
HAO, Z ;
PAULL, KD ;
SZEKERES, T ;
COONEY, DA ;
KROHN, K ;
JAYARAM, HN .
BIOCHEMICAL PHARMACOLOGY, 1994, 48 (07) :1413-1419
[9]   CNAD - A POTENT AND SPECIFIC INHIBITOR OF ALCOHOL-DEHYDROGENASE [J].
GOLDSTEIN, BM ;
LI, H ;
JONES, JP ;
BELL, JE ;
ZEIDLER, J ;
PANKIEWICZ, KW ;
WATANABE, KA .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (03) :392-399
[10]  
HARTMAN NR, 1991, MOL PHARMACOL, V40, P118